标题
Long-acting antiretrovirals and HIV treatment adherence
作者
关键词
-
出版物
Lancet HIV
Volume 10, Issue 5, Pages e332-e342
出版商
Elsevier BV
发表日期
2023-04-14
DOI
10.1016/s2352-3018(23)00051-6
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Phenotypic resistance to lenacapavir and monotherapy efficacy in a proof-of-concept clinical study
- (2022) Nicolas Margot et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Effects of behavioural interventions on postpartum retention and adherence among women with HIV on lifelong ART: the results of a cluster randomized trial in Kenya (the MOTIVATE trial)
- (2022) Lisa L. Abuogi et al. Journal of the International AIDS Society
- Long-acting injectable ART for HIV: a (cautious) step forward
- (2022) Priya Venkatesan Lancet Microbe
- Population pharmacokinetics of cabotegravir following administration of oral tablet and long‐acting intramuscular injection in adult HIV‐1‐infected and uninfected subjects
- (2022) Kelong Han et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- First Demonstration Project of Long-Acting Injectable Antiretroviral Therapy for Persons With and Without Detectable HIV Viremia in an Urban HIV Clinic
- (2022) Katerina A Christopoulos et al. CLINICAL INFECTIOUS DISEASES
- Compassionate use of long‐acting cabotegravir plus rilpivirine for people living with HIV ‐1 in need of parenteral antiretroviral therapy
- (2022) Ronald D'Amico et al. HIV MEDICINE
- Resistance Analyses in Highly Treatment-Experienced People With Human Immunodeficiency Virus (HIV) Treated With the Novel Capsid HIV Inhibitor Lenacapavir
- (2022) Nicolas A Margot et al. JOURNAL OF INFECTIOUS DISEASES
- Early Experience Implementing Long-Acting Injectable Cabotegravir/Rilpivirine for Human Immunodeficiency Virus-1 Treatment at a Ryan White-Funded Clinic in the US South
- (2022) Lauren F Collins et al. Open Forum Infectious Diseases
- 1582. Real-World Use of Long-Acting Cabotegravir + Rilpivirine in the US: Effectiveness in the First Year
- (2022) Michael G Sension et al. Open Forum Infectious Diseases
- 1584. CARISEL A Hybrid III Implementation Effectiveness Study of implementation of Cabotegravir plus Rilpivirine Long Acting (CAB+RPV LA) in EU Health Care Settings Key Clinical and Implementation Outcomes by Implementation Arm
- (2022) Stephane De Wit et al. Open Forum Infectious Diseases
- Early post-partum viremia predicts long-term non-suppression of viral load in HIV-positive women on ART in Malawi: Implications for the elimination of infant transmission
- (2021) Megan Landes et al. PLoS One
- Predictors of HIV-1 virologic failure to long-acting cabotegravir and rilpivirine
- (2021) Amy G. Cutrell et al. AIDS
- Characterization of HIV infection in cisgender men and transgender women who have sex with men receiving injectable cabotegravir for HIV prevention: HPTN 083
- (2021) Mark A Marzinke et al. JOURNAL OF INFECTIOUS DISEASES
- The potential role of long-acting injectable cabotegravir–rilpivirine in the treatment of HIV in sub-Saharan Africa: a modelling analysis
- (2021) Andrew N Phillips et al. Lancet Global Health
- Long-acting cabotegravir + rilpivirine for HIV-1 treatment
- (2021) Susan Swindells et al. AIDS
- Long-acting antiretrovirals: a new era for the management and prevention of HIV infection
- (2021) Paul Thoueille et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Population pharmacokinetics of the rilpivirine long-acting formulation after intramuscular dosing in healthy subjects and people living with HIV
- (2021) M Neyens et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Cabotegravir for HIV Prevention in Cisgender Men and Transgender Women
- (2021) Raphael J. Landovitz et al. NEW ENGLAND JOURNAL OF MEDICINE
- SMS messaging to improve retention and viral suppression in prevention of mother-to-child HIV transmission (PMTCT) programs in Kenya: A 3-arm randomized clinical trial
- (2021) John Kinuthia et al. PLOS MEDICINE
- Impact of long-acting therapies on the global HIV epidemic
- (2021) Nomathemba C. Chandiwana et al. AIDS
- A new paradigm for antiretroviral delivery: long-acting cabotegravir and rilpivirine for the treatment and prevention of HIV
- (2021) Sara H. Bares et al. Current Opinion in HIV and AIDS
- Long-acting cabotegravir and rilpivirine dosed every 2 months in adults with HIV-1 infection (ATLAS-2M), 96-week results: a randomised, multicentre, open-label, phase 3b, non-inferiority study
- (2021) Hans Jaeger et al. Lancet HIV
- Initiation of long-acting cabotegravir plus rilpivirine as direct-to-injection or with an oral lead-in in adults with HIV-1 infection: week 124 results of the open-label phase 3 FLAIR study
- (2021) Chloe Orkin et al. Lancet HIV
- Global estimates of viral suppression in children and adolescents and adults on antiretroviral therapy adjusted for missing viral load measurements: a multiregional, retrospective cohort study in 31 countries
- (2021) Win Min Han et al. Lancet HIV
- 885. Pregnancy Outcomes and Pharmacokinetics in Pregnant Women Living with HIV Exposed to Long-Acting Cabotegravir and Rilpivirine in Clinical Trials
- (2021) Parul Patel et al. Open Forum Infectious Diseases
- Tenofovir Diphosphate in Dried Blood Spots in Pregnant and Postpartum Women With HIV in Kenya: A Novel Approach to Measuring Peripartum Adherence
- (2021) Lisa L. Abuogi et al. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
- Characterization of Human Immunodeficiency Virus (HIV) Infections in Women Who Received Injectable Cabotegravir or Tenofovir Disoproxil Fumarate/Emtricitabine for HIV Prevention: HPTN 084
- (2021) Susan H Eshleman et al. JOURNAL OF INFECTIOUS DISEASES
- Long-Acting Cabotegravir and Rilpivirine after Oral Induction for HIV-1 Infection
- (2020) Chloe Orkin et al. NEW ENGLAND JOURNAL OF MEDICINE
- Long-Acting Cabotegravir and Rilpivirine for Maintenance of HIV-1 Suppression
- (2020) Susan Swindells et al. NEW ENGLAND JOURNAL OF MEDICINE
- Placental Transfer of the integrase strand inhibitors cabotegravir and bictegravir in the Ex-Vivo Human Cotyledon Perfusion Model
- (2020) Lucile Pencolé et al. AIDS
- Tail-phase safety, tolerability, and pharmacokinetics of long-acting injectable cabotegravir in HIV-uninfected adults: a secondary analysis of the HPTN 077 trial
- (2020) Raphael J Landovitz et al. Lancet HIV
- Adherence to HIV antiretroviral therapy among pregnant and postpartum women during the Option B+ era: 12‐month cohort study in urban South Africa and rural Uganda
- (2020) Lynn T Matthews et al. Journal of the International AIDS Society
- Adherence to HIV treatment regimens: systematic literature review and meta-analysis
- (2019) Frederick Altice et al. Patient Preference and Adherence
- Long-acting or extended-release antiretroviral products for HIV treatment and prevention in infants, children, adolescents, and pregnant and breastfeeding women: knowledge gaps and research priorities
- (2019) Sharon Nachman et al. Lancet HIV
- Text messaging for maternal and infant retention in prevention of mother-to-child HIV transmission services: A pragmatic stepped-wedge cluster-randomized trial in Kenya
- (2019) Thomas A. Odeny et al. PLOS MEDICINE
- 884. Patient Adherence to Long-Acting Injectable Cabotegravir + Rilpivirine Through 48 Weeks of Maintenance Therapy in the Phase 3 ATLAS and FLAIR Studies
- (2019) Paula Teichner et al. Open Forum Infectious Diseases
- Medication adherence in pregnant women with human immunodeficiency virus receiving antiretroviral therapy in sub-Saharan Africa: a systematic review
- (2018) Olumuyiwa Omonaiye et al. BMC PUBLIC HEALTH
- Rilpivirine Plasma and Cervicovaginal Concentrations in Women During Pregnancy and Postpartum
- (2018) Ahizechukwu C. Eke et al. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
- Experiences with long acting injectable ART: A qualitative study among PLHIV participating in a Phase II study of cabotegravir + rilpivirine (LATTE-2) in the United States and Spain
- (2018) Deanna Kerrigan et al. PLoS One
- Interest of Youth Living with HIV in Long-Acting Antiretrovirals
- (2018) Ethel D. Weld et al. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
- Interventions to significantly improve service uptake and retention of HIV-positive pregnant women and HIV-exposed infants along the prevention of mother-to-child transmission continuum of care: systematic review
- (2017) Alexandra C. Vrazo et al. TROPICAL MEDICINE & INTERNATIONAL HEALTH
- Pharmacokinetics of Rilpivirine in HIV-Infected Pregnant Women
- (2016) Anna H. Tran et al. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
- Effect of HIV Antibody VRC01 on Viral Rebound after Treatment Interruption
- (2016) Katharine J. Bar et al. NEW ENGLAND JOURNAL OF MEDICINE
- Pharmacokinetics of drugs in pregnancy
- (2015) Maisa Feghali et al. SEMINARS IN PERINATOLOGY
- Physiologic and pharmacokinetic changes in pregnancy
- (2014) Maged M. Costantine Frontiers in Pharmacology
- Adherence to antiretroviral therapy during and after pregnancy in low-income, middle-income, and high-income countries
- (2012) Jean B. Nachega et al. AIDS
- Altered drug metabolism during pregnancy: hormonal regulation of drug-metabolizing enzymes
- (2010) Hyunyoung Jeong Expert Opinion on Drug Metabolism & Toxicology
- Antiretroviral Therapy Adherence, Virologic and Immunologic Outcomes in Adolescents Compared With Adults in Southern Africa
- (2009) Jean B Nachega et al. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started